VALUEMAP Valuemap: Enabling Value-sharing and Adoption of Health Data Business Models
- Coordinator
- Eit Health Innostars eV, Germany
- Runs
- 1 September 2026 to 29 February 2028
- Status
- Running
- EU funding
- €990k
- Total cost
- —
- Partners
- 9 organisations in 6 countries
- Type
- Coordination and Support Action
- Grant agreement
- 101304748
What the project is doing
In the project's own words, from its summary on CORDIS.
VALUEMAP accelerates adoption of EHDS-aligned, fair and sustainable business models for the secondary use of health data by turning fragmented practices into a shared, actionable European playbook. Led by EIT Health InnoStars with a multi-country, multi-stakeholder consortium, the project builds on an EIT Health Special Interest Group and targets more interconnected, inclusive and efficient health-data ecosystems. Phase 1 (Assess & Map) combines a European desk study, a pan-EU stakeholder survey, targeted interviews, five national multi-stakeholder roundtables, and an interregional synthesis workshop to distil opportunities, bottlenecks and key design choices across regions and actors.
Phase 2 (From evidence to action) establishes an Interregional Health Data Business Models Advisory Board to validate a prioritised set of recommendations, and co-designs two implementation-ready outputs: a multi-annual Joint Action Plan and a European collection of Best Practices & Toolkits (templates, model clauses, adoption roadmaps) that are locally adaptable yet interoperable across borders. Cross-cutting principles include inclusive participation (patients/citizens, SMEs, regional hospitals), GDPR-compliant data management, and structured synergies with EU flagship initiatives (e.g., TEHDAS2, DARWIN EU, EHDEN, HDABs, HealthData@EU) to align vocabulary, avoid duplication and speed reuse.
Expected results: a consensus-based plan and reusable toolkit enabling co-planning, co-implementation and co-investment; stronger links between innovators and authorities; and measurable uptake via an exploitation plan and early-adopter pathways—ultimately improving evidence generation, accelerating innovation and delivering better health outcomes.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Eit Health Innostars eV | Munchen | Germany | Coordinator |
| Naucnoistrazivacki Institut Verlab Za Biomedicinski Inzinjering Medicinske Uredaje I Vjestacku Inteligenciju | Sarajevo | Bosnia and Herzegovina | Participant |
| Consejeria De Sanidad De La Comunidad De Madrid | Madrid | Spain | Participant |
| Fundacion Para La Investigacion E Innovacion Biosanitaria De Atencion Primaria | Madrid | Spain | Third party |
| Fundacion Publica Andaluza Progreso Y Salud M.p. | Sevilla | Spain | Participant |
| Institut Catala De La Salut | Barcelona | Spain | Participant |
| Takeda Products Ireland Ltd | Dublin | Ireland | Associatedpartner |
| Associacao Colabtrials Laboratorio Colaborativo Para a Inovacao Em Ensaios Clinicos | Evora | Portugal | Participant |
| Karolinska Institutet | Stockholm | Sweden | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI